Novartis announced the company’s financial results for the first quarter of 2020.
This year, World Malaria Day is happening as countries around the world are fighting the COVID-19 pandemic.
The Corporate Reputation of Pharma 2019 global report reflects the findings of a survey conducted by PatientView with patient organizations worldwide.
Novartis is committed to reimagining the fight against Chagas Disease and advocating for an integrated, end-to-end care approach.
Novartis COVID-19 Response Fund is providing urgently-needed support for healthcare workers and communities in over 50 projects around the world.
Read and download the Annual Review, the Annual Report and Form 20-F, and the Novartis in Society ESG report.
This site is intended for a global audience.